Events
The MD Anderson Cancer Neuroscience Program and Wiley's Advanced Portfolio proudly announce the 3rd biennial International Cancer Neuroscience Symposium happening on February 18–20, 2026 in the Texas Medical Center! This dynamic, three-day hybrid event will feature key insights and the latest, cutting-edge research from more than 30 leading international experts in the field of cancer neuroscience.
Several keynote speakers are confirmed, including Nobel Laureate Dr. James P. Allison, Dr. Shawn Hervey-Jumper, Dr. Guido Kroemer, Dr. Frank Winkler, Dr. Sebastien Talbot and Dr. Erica Sloan.
The goal of this event is to bring together world-renowned experts in oncology, neuroscience, cancer biology, neuro-immunology, neurotoxicity and mental health to foster innovation in cancer research and patient care through a unique integration of these disciplines. Several compelling sessions are planned including the "Inflamed Scientists" panel discussion, oral abstract competition and more! Join us for this exciting and interactive event!
NOTE: Registration will close on FEBRUARY 1, 2026! In-person spots filling quickly! Take advantage of the LOW COST ($150) to attend three full days of cutting-edge science and two evening receptions with live music and more!
Mei Rui at a Music-in-Medicine concert
The MD Anderson Cancer Neuroscience Program is proud to champion the work of the Music-in-Medicine Program. This unique concert series is led by Mei Rui, D.M.A., a globally renowned, classically trained concert pianist and assistant professor of Neurosurgery. The series brings world-class musicians from around the globe to perform for patients, caregivers, families, staff and visitors. These immersive concerts offer a powerful experience of music’s healing potential. As an integral component of several of Dr. Rui’s clinical trials, these live performances integrate real-time brain-computer interface mapping and neurophysiological data collections on stress and inflammatory biomarkers and brain dynamics to quantitatively capture and assess the powerful therapeutic impact of an immersive live performance on cancer patients, providers and caregivers.